Boston Scientific lands FDA win for new stent lengths | Regulatory Roundup

 Boston Scientific lands FDA win for new stent sizes
Boston Scientific (NYSE:BSX) touted FDA clearance for the 32 mm and 28 mm lengths of its Promus Element Plus drug-eluting stents, which the med-tech giant claims now represents the broadest array of everolimus-eluting lengths and diameters in the U.S.
Read more

 Nevro wins the FDA’s okay to launch a pivotal trial of its spinal cord stimulator
Menlo Park, Calif.-based Nevro Corp. announced FDA approval to begin a pivotal trial of its high-frequency spinal cord stimulation system for the treatment of chronic pain.  
Read more

 MitrAssist touts ISO certification for design and development of heart valves
Israel’s MitrAssist Medical won ISO certification affirming its design and development of implantable heart valve prostheses.  
Read more